Eaton Vance Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.74M | Buy |
36,093
+1,454
| +4% | +$110K | ﹤0.01% | 950 |
|
|
2022
Q2 | $2.41M | Sell |
34,639
-76
| -0.2% | -$5.28K | ﹤0.01% | 1022 |
|
|
2022
Q1 | $2.88M | Buy |
34,715
+20,611
| +146% | +$1.71M | ﹤0.01% | 1064 |
|
|
2021
Q4 | $1.06M | Sell |
14,104
-48
| -0.3% | -$3.6K | ﹤0.01% | 1167 |
|
|
2021
Q3 | $1.62M | Buy |
14,152
+123
| +0.9% | +$14.1K | ﹤0.01% | 974 |
|
|
2021
Q2 | $3.11M | Buy |
14,029
+29
| +0.2% | +$6.43K | ﹤0.01% | 905 |
|
|
2021
Q1 | $1.85M | Buy |
14,000
+6
| +0% | +$793 | ﹤0.01% | 994 |
|
|
2020
Q4 | $2.42M | Sell |
13,994
-18
| -0.1% | -$3.12K | ﹤0.01% | 885 |
|
|
2020
Q3 | $1.56M | Hold |
14,012
| – | – | ﹤0.01% | 900 |
|
|
2020
Q2 | $831K | Hold |
14,012
| – | – | ﹤0.01% | 999 |
|
|
2020
Q1 | $944K | Hold |
14,012
| – | – | ﹤0.01% | 918 |
|
|
2019
Q4 | $1.18M | Hold |
14,012
| – | – | ﹤0.01% | 942 |
|
|
2019
Q3 | $1.05M | Buy |
+14,012
| New | +$1.05M | ﹤0.01% | 946 |
|